Latest news

  • ASIT biotech reintroduces an application for judicial reorganization and modifies the composition of its board of directors Monday, 20 January 2020
  • ASIT Biotech_next steps Friday, 20 December 2019
  • ASIT biotech gp-ASIT+TM Phase III trial in grass pollen allergy did not meet the primary endpoint Monday, 25 November 2019
  • All ASIT news


Share Price :
0.2105 EUR
Previous close: 0.212 EUR